Demystifying Insmed: Insights From 7 Analyst Reviews
Demystifying Insmed: Insights From 7 Analyst Reviews
揭开insmed的神秘面纱：来自7位分析师的见解
A clear picture of Insmed's perception among...Throughout the last three months, 7 analysts have evaluated Insmed (NASDAQ:INSM), offering a diverse set of opinions from bullish to bearish.
在过去三个月中，7位分析师对insmed（纳斯达克:INSM）进行了评估，提供了从看好到看淡的多样化观点。
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
下表总结了他们最近的评级，展示了过去30天内不断变化的情绪，并将其与前几个月进行了比较。
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $89.71, a high estimate of $105.00, and a low estimate of $74.00. This upward trend is evident, with the current average reflecting a 5.54% increase from the previous average price target of $85.00.
分析师评估的12个月价格目标显示了进一步的见解，平均目标为89.71美元，高估计为105.00美元，低估计为74.00美元。这个上升趋势显而易见，目前的平均值反映出比之前85.00美元的平均价格目标增加了5.54%。
Investigating Analyst Ratings: An Elaborate Study
分析师评级的调查：一项详尽的研究
A clear picture of Insmed's perception among...
对insmed在...
登录免费看全文
登录/注册
资讯热榜
更新时间